Drug – bio-affecting and body treating compositions – Inorganic active ingredient containing – Heavy metal or compound thereof
Patent
1997-04-08
1999-03-30
Dees, Jose' G.
Drug, bio-affecting and body treating compositions
Inorganic active ingredient containing
Heavy metal or compound thereof
514 6, 514184, 514505, A01N 5916, A01N 5710, A01N 5502, A61K 3816
Patent
active
058885536
ABSTRACT:
A non-steroid containing anabolic nutrient formulation for the building and sustaining of muscle mass in humans or other warm-blooded animals, that enables the body to synthesize and maintain muscle at a mass and in a manner optimally suited to the genetic makeup of that person or animal. The formulation comprises effective amounts of a chromium salt, complex or chelate and a magnesium glycyl glutaminate chelate. Optionally, one or more additional nutrients selected from the group consisting of a magnesium amino acid chelate or proteinate, an .alpha.-glutaric acid salt of ornithine, creatine or a salt thereof, and a branched chain amino acid selected from the group consisting of leucine, isoleucine and valine and mixtures thereof may be included.
REFERENCES:
patent: 4020158 (1977-04-01), Ashmead et al.
patent: 4076803 (1978-02-01), Ashmead
patent: 4167564 (1979-09-01), Jensen
patent: 4599152 (1986-07-01), Ashmead
patent: 4774089 (1988-09-01), Ashmead
patent: 4830716 (1989-05-01), Ashmead
patent: 4863898 (1989-09-01), Ashmead et al.
patent: 4954492 (1990-09-01), Jensen
Sartin et al. Plasma Concentrations of Metabolic Hormones in High and Low Producing Dairy Cows, 71 J. Dairy Sci. 650-657, 1988.
Schrauzer, et al. Effects of Chromium Supplementation on Food Energy Utilization and the Trace-Element Composition in the Liver and Heart of Glucose-Exposed Young Mice, 9 Biol. Trace Element Res. 79, 1986.
Polansky, et al. Beneficial Effects of Supplemental Chromium (Cr) on Glucose, Insulin and Glucagon of Subjects Consuming Controlled Low Chromium Diets, FASEB J. A2964, 1990.
Satterlee et al. Vitamin C Amelioration of the Adrenal Stress Response in Broiler Chickens being Prepared for Slaughter, 94A Comp. Biochem. Physiol. 569-574, 1989.
Munck et al. Physiological Functions of Glucocorticoids in Stress and Their Relation to Pharmacological Actions, 5 Endoc. Rev. 25, 1984.
Southorn et al. The Effect of Corticosterone Treatment of the Response of Muscle Protein Synthesis to Insulin Infusion in the Rat, 23 J. Endocrin. Abst. #127, 1989.
Rennie et al. Glutamine Transport and Its Metabolic Effects, 124 J. Nutri. 1503S-1508S, 1994.
Gore et al. Glutamine Kinetics in Burn Patients, 129 Arch. Surg. 1318-1323, 1994.
Young et al. Patients Receiving Glutamine-Supplemented Intravenous Feedings Report an Improvement in Mood, 17 J. Parenteral and Enteral Nutrition, 422-427, 1993.
Ashmead H. DeWayne
Bynum Stanley A
Grant Douglas D.
Albion International, Inc.
Dees Jos,e G.
Infinity Inc.
Pryor Alton
LandOfFree
Non-steroidal anabolic composition does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Non-steroidal anabolic composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Non-steroidal anabolic composition will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1212173